Bo Yang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Oxidative medicine and cellular longevity

British journal of pharmacology

Expert opinion on pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Ding, Hongjie Guo, Jie Zhang, Mingming Zheng, Wenjie Zhang, Longsheng Wang, Qianqian Du, Chen Zhou, Yanjun Xu, Honghai Wu, Qiaojun He, Bo Yang
Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD-L1. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
Xiaohui Pan, Wenxin Zhang, Longsheng Wang, Hongjie Guo, Mingming Zheng, Honghai Wu, Qinjie Weng, Qiaojun He, Ling Ding, Bo Yang
KLF12 transcriptionally regulates PD-L1 expression in non-small cell lung cancer. Molecular oncology (2023)
Hao Yan, Xiangliang Huang, Jiangxin Xu, Ying Zhang, Jiajia Chen, Zhifei Xu, Hui Li, Zeng Wang, Xiaochun Yang, Bo Yang, Qiaojun He, Peihua Luo
Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13-Mediated Stabilization of Bcl-XL. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Yourong Zhou, Yiming Yin, Jiangxin Xu, Jiangxin Xu, Bo Yang, Qiaojun He, Peihua Luo, Hao Yan, Xiaochun Yang
An update on Alectinib: a first line treatment for ALK-positive advanced lung cancer. Expert opinion on pharmacotherapy (2023)
Minshan Lai, Qiang Liu, Wenbo Chen, Xuxin Qi, Jianfeng Yang, Li Jiang, Meng Yuan, Zhichun Liu, Qiaojun He, Ji Cao, Bo Yang
Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis. Oxidative medicine and cellular longevity 2022 (2022)
Li Jiang, Rong Dong, Meidan Ying, Qiaojun He, Ji Cao, Bo Yang
Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics. British journal of pharmacology 175 (23) (2018)